UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 OR ☐ Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File Number: 0-21810 GENTHERM INCORPORATED (Exact name of registrant as specified in its charter) Michigan 95-4318554 (State or other jurisdict ...

Gentherm (THRM) Q2 2025 Earnings Call July 24, 2025 08:00 AM ET Speaker0Greetings, and welcome to the Gentherm Second Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A question and answer As a reminder, this conference is being recorded. It is now my pleasure to introduce Gregory Blanchett, Senior Director, Investor Relations. Please go ahead.Speaker1Thank you, and good morning, everyone. Thanks for joining us today. Gentherm's earnings results ...

Gentherm (THRM) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -8.47%. A quarter ago, it was expected that this maker of climate-controlled seats and other products would post earnings of $0.48 per share when it actually produced earnings of $0.51, delivering a surprise of +6.25%.Ove ...

2025 Second Quarter Results July 24, 2025 Proprietary © Gentherm Forward-Looking Statements Except for historical information contained herein, statements in this presentation are forward-looking statements that are made by Gentherm Incorporated (the "Company") pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements that address future operating, financial or business performance or strategies or expectations are forward-looking statements. The forward- ...

"The Gentherm team delivered second quarter results in line with our expectations, with adjusted EBITDA improving sequentially, and strong commercial performance. Our Automotive New Business Awards reached over $1 billion year-to-date as a result of our continued innovation, technology leadership, and strong customer relationships," said Bill Presley, the Company's President and CEO. Second Quarter Highlights Presley concluded, "Our focus remains on executing our strategic priorities, while driving operatin ...

Core Insights - Gentherm reported second quarter 2025 financial results with delivered revenue of $375 million, including a record for Automotive Climate and Comfort Solutions [1][2] - The company secured over $600 million in new automotive business awards during the quarter, totaling $1 billion year-to-date [1][3] - Full-year guidance for 2025 has been narrowed, with product revenues expected between $1.43 billion and $1.5 billion [5] Financial Performance - Product revenues of $375.1 million decreased by 0.2% from $375.7 million in the prior year, with a 1.6% decrease when excluding foreign currency translation [6] - Automotive revenues decreased by 1.5%, while Medical revenues decreased by 4.8% [6] - Adjusted EBITDA was $45.9 million, representing 12.2% of revenue, down from $49.9 million or 13.3% of revenue in the prior year [6][26] Revenue Breakdown - Automotive Climate and Comfort Solutions revenue increased by 3.8% year-over-year, outperforming S&P Global's light vehicle production report by 10 basis points [6] - The company secured automotive new business awards totaling $620 million, including significant contracts with Ford [6][3] - Revenue from Climate Control Seats was $200 million, showing a slight increase, while Lumbar and Massage Comfort Solutions saw a 14.5% increase [23] Guidance and Strategic Focus - The revised guidance for adjusted EBITDA margin rate is set between 11.7% and 12.5% for the full year 2025 [5] - The company is focused on executing strategic priorities and driving operational efficiencies despite macroeconomic uncertainties [5][3] - Capital expenditures guidance has been reduced to $55 million to $65 million from the previous range of $70 million to $80 million [5] Market Position and Outlook - Gentherm maintains a strong liquidity position with $416 million available, reflecting an increase from the previous year [33] - The company continues to innovate and strengthen customer relationships, contributing to its market leadership in thermal management technologies [3][11] - The overall market sentiment has improved, but the company remains cautious in its operational management due to ongoing uncertainties [5]

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use a variety of methods, in ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than the traditional "buying low and selling high" approach, aiming for quicker profits [1] Group 1: Momentum Investing Characteristics - Fast-moving trending stocks can be difficult to enter at the right time, as they may lose momentum if future growth does not justify their high valuations [2] - Investing in bargain stocks that have recently shown price momentum can be a safer strategy, utilizing tools like the Zacks Momentum Style Score to identify potential opportunities [3] Group 2: Gentherm (THRM) Analysis - Gentherm (THRM) has shown a four-week price change of 14.4%, indicating growing investor interest [4] - Over the past 12 weeks, THRM's stock has gained 24.2%, with a beta of 1.42, suggesting it moves 42% more than the market [5] - THRM has a Momentum Score of B, indicating a favorable time to invest based on momentum [6] Group 3: Earnings Estimates and Valuation - THRM has received a Zacks Rank 1 (Strong Buy) due to upward revisions in earnings estimates, which typically attract more investors [7] - The stock is currently trading at a Price-to-Sales ratio of 0.68, suggesting it is undervalued at 68 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides THRM, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]

Company Overview - Gentherm (NASDAQ: THRM) is a global market leader in innovative thermal management and pneumatic comfort technologies [4] - The company offers automotive products such as Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems [4] - In the medical sector, Gentherm provides patient temperature management systems [4] - The company employs over 14,000 people across 13 countries [4] Financial Performance - Gentherm recorded annual sales of approximately $1.5 billion in 2024 [4] - The company secured $2.4 billion in new business awards in the automotive sector [4] Upcoming Events - Gentherm will report its financial results for the second quarter of 2025 on July 24, 2025 [1] - A conference call to discuss these results will take place at 8 am (ET) on the same day [1]

Core Insights - Gentherm expands its partnership with DUOMED into France, enhancing patient temperature management technologies across Europe [1][2] - DUOMED will distribute Gentherm's full patient temperature management portfolio, including the Astopad and Vytil-branded systems [2] - The partnership aims to leverage DUOMED's strong presence and relationships in Europe to improve healthcare delivery [3][4] Company Overview - Gentherm is a global leader in thermal management and pneumatic comfort technologies, with a diverse product range in automotive and medical sectors [5] - In 2024, Gentherm reported annual sales of approximately $1.5 billion and secured $2.4 billion in new automotive business awards [5] - DUOMED, part of the Palex group, specializes in medical technology sales, consultancy, and support, focusing on high-quality solutions for healthcare professionals [6] Product Insights - The Astopad resistive warming system and Vytil-branded convective warming system are key offerings in the partnership [2] - Early feedback from French clinicians indicates a preference for Vytil blankets due to their superior quality compared to competitors [4] - Vytil products are recognized for their quality, safety, and value, with a focus on usability and innovation [7]